Candel Therapeutics Inc (CADL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $486.37M
Last updated: Nov 17, 2026 at 4:35 PM ET
Candel Therapeutics Inc (CADL) Stock Chart
Candel Therapeutics (CADL) has a latest price of $5.40 on Nov 17, 2026, 61.4% below its 52-week high of $14.00. Its price rose 16.4% over the past 12 months. The month-end price fell 25.8% over the 5 years through Oct 2026, a compound annual decline of 5.8%.
Price Chart
From Jul 2021 to Oct 2026, its highest month-end close was $13.07 in Aug 2026 and its lowest $0.90 in Nov 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CADL with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CADL.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 60.0%, and over 6 months it fell 29.5%. The month-end price rose 825.7% over the 3 years through Oct 2026, a compound annual rate of 110.0%.
| Period | Change |
|---|---|
| 1 month | -34.2% |
| 3 months | -60.0% |
| 6 months | -29.5% |
| 12 months | +16.4% |
| 12 months, with dividends | +16.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +825.7% | +110.0% |
| 5 years | -25.8% | -5.8% |
Price by Year
Its best calendar year was 2024, when the price rose 490.5%, and its weakest was 2022, when it fell 77.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $8.33 | +47.4% |
| 2025 | $5.65 | -34.9% |
| 2024 | $8.68 | +490.5% |
| 2023 | $1.47 | -17.9% |
| 2022 | $1.79 | -77.1% |
Trading Range
The price is 43.0% below its 50-day average of $9.47 and 35.7% below its 200-day average of $8.40.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $5.40 | |
| 52-week high | $14.00 | -61.4% |
| 52-week low | $4.35 | +24.1% |
| 50-day average | $9.47 | -43.0% |
| 200-day average | $8.40 | -35.7% |
Price Risk
Over 3 years, its largest fall from a peak was 72.9%.
| Measure | Value |
|---|---|
| 1-year beta | 2.19 |
| Largest fall, 1 year | -60.7% |
| Largest fall, 3 years | -72.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CADL
What is CADL's 1-year price change?
Candel Therapeutics's price rose 16.4% over the past 12 months. With dividends included, the 12-month total return was 16.4%.
What is CADL's 5-year price change?
Candel Therapeutics's month-end price fell 25.8% over the 5 years through Oct 2026, a compound annual decline of 5.8%. These figures leave out dividends.
What is CADL's 52-week high and low?
Candel Therapeutics's 52-week high is $14.00 and its 52-week low is $4.35. Its latest price of $5.40 on Nov 17, 2026 is 61.4% below the high.
What is CADL's beta?
Candel Therapeutics's 1-year beta against the S&P 500 is 2.19, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 60.7%.
Is the CADL chart free?
Yes. Advanced Charting for CADL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CADL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors